Ticker League

Estimates for Intuitive Surgical (ISRG)

Analyst consensus revenue & EPS estimates for Intuitive Surgical (ISRG) — Q3 2026. Compare the numbers and make your own prediction.

Consensus EPS · Q3 2026

$2.63

Consensus revenue · Q3 2026

$2.9B

Analysts

16

Expected report

Oct 20, 2026

After close
Upcoming earnings
Locks in 89 days 7 hours · AMC: Locks at 4:00 PM ET on report day
Revenue$2.9B$2.8B $3B
EPS$2.63$2.53 $2.76

What to watch

  • Analyst ratings: Mixed
Make your prediction

Analyst consensus

Based on estimates from 16 analysts.

  • Revenue$2.9B
  • EPS$2.63
  • EBITDA$1B
  • EBIT$878.3M
  • Net income$943.8M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

  • Q2 2026+2.4%+11.5%
  • Q1 2026+5.8%+17.8%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Intuitive Surgical (ISRG) Q3 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 15 analysts.

Low
$400.00
Consensus
$525.00
Median
$505.00
High
$750.00
Current
$340.69
Upside
+54.1%

Upside calculated vs most recent trading price of $340.69.

Analyst ratings

Consensus: Buy — based on 56 analyst ratings.

Buy 39Hold 12Sell 5

24-month trend

Recent analyst actions

  • Jul 17, 2026Wells FargoOverweight
  • Jul 17, 2026TD CowenBuy
  • Jul 17, 2026StifelBuy
  • Jul 17, 2026RBC CapitalOutperform
  • Jul 17, 2026Raymond JamesOutperform
  • Jul 17, 2026Piper SandlerOverweight
  • Jul 17, 2026MizuhoNeutral
  • Jul 17, 2026Leerink PartnersOutperform
  • Jul 17, 2026JP MorganOverweight
  • Jul 17, 2026Evercore ISI GroupIn Line

Frequently asked questions

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation